E. François Aldrich

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Daniel F. Hanley, Richard E. Thompson, Michael Rosenblum et al. · The Lancet · 2019 · 850 citations · Full text

Thrombosis, Endpoint Phase 3, Interventional Neuroradiology +12

Initial CT findings in 753 patients with severe head injury

Howard M. Eisenberg, Howard E. Gary, E. François Aldrich et al. · Journal of neurosurgery · 1990 · 611 citations

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up

M B Bracken, M J Shepard, Theodore R. Holford et al. · Journal of neurosurgery · 1998 · 532 citations

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial

Daniel F. Hanley, Karen Lane, Nichol McBee et al. · The Lancet · 2017 · 473 citations · Full text

Thrombosis, Intraventricular Haemorrhage, Interventional Neuroradiology +11

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.

Theodore R. Holford, Linda Leo‐Summers, E. François Aldrich et al. · PubMed · 1997 · 457 citations